• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Pressure IQ Evolve Mattress

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Pressure IQ Evolve Mattress see related information
Date Initiated by Firm September 01, 2014
Date Posted March 06, 2015
Recall Status1 Terminated 3 on January 04, 2016
Recall Number Z-1247-2015
Recall Event ID 68235
Product Classification Mattress, flotation therapy, non-powered - Product Code IKY
Product Pressure IQ Evolve Mattress; Non-powered mattress replacement system.

Intended for patients with medium to high risk for developing pressure ulcers while on a mattress.
Code Information All Pressure IQ Evolve mattresses equipped with the 60g pods, manufactured January 2012-December 2013.
Recalling Firm/
Manufacturer
Arjo Hospital Equipment AB
HANS MICHELSENSGATAN 10
Malm¿ Sweden
For Additional Information Contact
210-515-4251
Manufacturer Reason
for Recall
The firm received complaints regarding multiple mattresses were showing failures resulting in pressure ulcers.
FDA Determined
Cause 2
Device Design
Action On 9/1/14 the recalling firm sent out a letter to their customers notifying them of an updated IFU for the recalled device. The letter also requested the customers to verify the quantity of the product they currently have on hand.
Quantity in Commerce 1,034 units
Distribution Nationwide Distribution.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-